首页    期刊浏览 2025年05月26日 星期一
登录注册

文章基本信息

  • 标题:Health Care Provider Recommendation, Human Papillomavirus Vaccination, and Race/Ethnicity in the US National Immunization Survey
  • 本地全文:下载
  • 作者:Kelly R. Ylitalo ; Hedwig Lee ; Neil K. Mehta
  • 期刊名称:American journal of public health
  • 印刷版ISSN:0090-0036
  • 出版年度:2013
  • 卷号:103
  • 期号:1
  • 页码:164-169
  • DOI:10.2105/AJPH.2011.300600
  • 语种:English
  • 出版社:American Public Health Association
  • 摘要:Objectives. Human papillomavirus (HPV) is a common sexually transmitted infection in the United States, yet HPV vaccination rates remain relatively low. We examined racial/ethnic differences in the prevalence of health care provider recommendations for HPV vaccination and the association between recommendation and vaccination. Methods. We used the 2009 National Immunization Survey–Teen, a nationally representative cross-section of female adolescents aged 13 to 17 years, to assess provider-verified HPV vaccination (≥ 1 dose) and participant-reported health care provider recommendation for the HPV vaccine. Results. More than half (56.9%) of female adolescents received a recommendation for the HPV vaccine, and adolescents with a recommendation were almost 5 times as likely to receive a vaccine (odds ratio = 4.81; 95% confidence interval = 4.01, 5.77) as those without a recommendation. Racial/ethnic minorities were less likely to receive a recommendation, but the association between recommendation and vaccination appeared strong for all racial/ethnic groups. Conclusions. Provider recommendations were strongly associated with HPV vaccination. Racial/ethnic minorities and non-Hispanic Whites were equally likely to obtain an HPV vaccine after receiving a recommendation. Vaccine education efforts should target health care providers to increase recommendations, particularly among racial/ethnic minority populations. Human papillomavirus (HPV) is one of the most common sexually transmitted infections in the United States. 1,2 In 2006, the Food and Drug Administration (FDA) licensed the first HPV vaccine for use in females aged 9 to 26 years. Subsequently, the Advisory Committee on Immunization Practices (ACIP) recommended routine HPV vaccination of 11- and 12-year-old girls, with ensuing catch-up vaccinations recommended for older female adolescents and young adults. 3 However, HPV vaccine coverage of adolescents remains less than 50%, 4 and Healthy People 2020 recognizes the facilitation of HPV vaccination as an emerging issue in sexually transmitted diseases. 5 Health care provider recommendation has been shown to be a strong predictor of vaccination for a wide range of vaccines in older age groups. 6–8 Therefore, one potential explanation for the low levels of HPV vaccine coverage is that parents and adolescents are not receiving HPV vaccine recommendations from their health care providers. A previous study indicated that less than 40% of adolescents discussed the HPV vaccine with their health care provider. 9 African Americans and other minority groups are disproportionately affected by HPV infection and subsequent cervical cancer compared with non-Hispanic Whites. 10,11 A better understanding of how to prevent HPV infection among racial/ethnic minorities will have important implications for reducing these health disparities. At the national level, little is known about racial/ethnic differences in the likelihood of receiving an HPV vaccine recommendation by a health care provider. In addition, little is known about the association between receiving a provider recommendation and actual HPV vaccine receipt and whether this association differs by race/ethnicity. Using the National Immunization Survey (NIS), a nationally representative sample of female adolescents aged 13 to 17 years in the United States, we examined racial/ethnic differences in the prevalence of health care provider recommendations for HPV vaccination and in the association between provider recommendation and provider-verified HPV vaccine initiation. In addition, we examined the roles of parental socioeconomic status and health insurance status in influencing the likelihood of provider recommendation and vaccine initiation.
国家哲学社会科学文献中心版权所有